Although not everyone agrees on the definition of chemogenomics, most believe the field holds great promise for the pharmaceutical industry. In its broadest sense, chemogenomics describes how a ...

CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 /Archetype Therapeutics, an AI-native company pioneering the integrative use of generative chemogenomics in drug discovery, announced today that it has ...

You have full access to this article via your institution. Among other measures, the chemical biology community should adopt a culture of curation as a mandatory component of primary data ...

Iconix Pharmaceuticals, Inc. has announced that it entered into a research and license agreement with Eli Lilly and Company. Iconix will receive compensation from Lilly in exchange for access to ...

Dubbed INDIGO, short for INferring Drug Interactions using chemoGenomics and Orthology, the software tool has shown that the potency of tuberculosis drugs can be amplified when they are teamed ...

Bristol-Myers will access Iconix's DrugMatrix chemogenomics system, which comprises information on the genomic effects of drug and chemical treatments, along with its library of Drug Signatures - more ...

Iconix Pharmaceuticals Inc.'s chemogenomics platform bagged another big-name pharma deal, this time signing up Eli Lilly and Co. to a research and license agreement described as "similar in scope" to ...

Philanthropic acquisition gives the academic chemogenomics community invaluable access to well-curated proprietary data. The Wellcome Trust has recently awarded a 5-year, UK£4.7 million grant to ...

Iconix Pharmaceuticals, Inc. has announced that it entered into a research and license agreement with Eli Lilly and Company.. Iconix will receive compensation from Lilly in exchange for access to ...